Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-06-29 @ 8:46 AM
Study NCT ID:
NCT07141004
Status:
RECRUITING
Last Update Posted:
2025-12-24
First Post:
2025-08-21
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Guselkumab Administered Subcutaneously in Treatment of Indian Participants With Psoriatic Arthritis (PsA)
Sponsor:
Johnson & Johnson Private Limited
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Arthritis, Psoriatic | View |
Keywords: